Navigation Links
AXA Equitable Helps Americans Prepare for a Long Retirement
Date:2/25/2008

New 200% Benefit Base Guarantee Available with Accumulator(R) Variable

Annuity

NEW YORK, Feb. 25 /PRNewswire-FirstCall/ -- Acknowledging that Americans are living longer than ever in retirement, AXA Equitable Life Insurance Company is offering a new way to help them afford the lifestyle they choose. The newest rider available with the company's top-selling Accumulator(R) variable annuity provides for a minimum 200% benefit base guarantee if no withdrawals are taken during the first 10 years of the contract or until age 70, whichever is later.

This means that a person who makes an initial contribution of $100,000 will have a minimum $200,000 benefit base after the later of the 10th anniversary of the contract or when turning 70 if no withdrawals have been made before that date.

"Because of the uncertainty of the financial markets, it may be difficult for people to predict exactly how much money they'll be able to spend in retirement," said Claude Methot, AXA Equitable's Senior Vice President and Chief Product Officer. "One way for them to guarantee part of their income is to purchase a variable annuity that will allow them to withdraw a certain percentage every year for life."

The Guaranteed Withdrawal Benefit for Life (GWBL) optional rider available with the Accumulator assures that the owner will receive a minimum amount of money every year for life, regardless of the market's performance. The guaranteed withdrawal percentage is determined by the owner's age at the time of the first withdrawal; it can range from 4% to as much as 7% of the benefit base.

Moreover, the owner may see increases in the withdrawal percentage if he or she experiences a ratchet during an age band change. For example, owners who are 45 to 59 years old may withdraw 4% of the benefit base. But, if good performance causes the benefit base to ratchet, owners who are 60 to 75 may withdraw 5% of the benefit base going for
'/>"/>

SOURCE AXA Equitable
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine news :

1. AUDIO from Medialink and AXA Equitable: Timing Retirement Thinking
2. Can world prize competitions foster more equitable drug research and development?
3. AXA Equitable Makes it Easier to Stop Ignoring Life Insurance
4. San Francisco Bay Area Autism Speaks Chapter Endorses Blue Ribbon Commission on Autism Recommendations for Equitable Insurance Coverage for Children With Autism
5. David Kahal Joins AXA Equitable as National Sales Manager
6. AXA Equitable Life Insurance Co. Hires William McDermott to Lead Corporate Retirement Planning Business
7. Shoe Therapy Helps Survivors Celebrate Life After Abuse
8. LifeSync Hires Dr. Mark Phelps to Lead Research & Development
9. Yes, no, maybe so: New model helps identify what works in mental health treatment
10. His Royal Highness The Duke of York Helps Launch UK-Based Pharmaceutical Company, ProStrakan, in the United States
11. Virtual Hold Technology Donates Toys, Helps Raise Money for WKDDs Annual Radiothon for Akron Childrens Hospital

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/27/2009)...27 Shamir Optical Indust...rovider of innovative products and technology to t...s board of directors had declared a dividend distr...approximately NIS 37.62 million based on the Novem...approximately US$ 0.609 (approximately NIS 2.3 bas...
(Date:11/27/2009)...ical, economic burdens, study predicts , ...of people with diabetes in the United States is ex...dy predicts. , That would bring the total by 20...up from 23.7 million today. , , At the same time...riple, the study also warns, rising from an estima...
(Date:11/27/2009)...bilingual coloring books designed for children age...ity to educate - inform parents and children alike...nosuars to ABC,S and a host of other topics. , ...mber 27, 2009 -- Today’s children have enoug...ny hour of the day, but one of the oldest and simp...
(Date:11/26/2009)...e/ -- With cold and flu season upon us, it,s more ...ntrol the spread of infections and avoid illness. ...rselves healthy, but to avoid transmitting illness...(certified in infection-control), nursing director...Hospital for Special Surgery (HSS) in Manhattan. ,...
(Date:11/26/2009)...molybdate (TM) has been shown in studies to be eff...se caused by an overload of copper, and certain me... however, is known about how the drug works at the...ern University researchers now has provided an inv...M bound to copper-loaded metallochaperones. The dr...
Breaking Medicine News(10 mins):Health News:Shamir Optical Industry Ltd. Announces Declaration of a Cash Dividend 2Health News:Shamir Optical Industry Ltd. Announces Declaration of a Cash Dividend 3Health News:Diabetes Cases Expected to Double in 25 Years 2Health News:Diabetes Cases Expected to Double in 25 Years 3Health News:Really Big Coloring Books Debuts Bi-Lingual Spanish-English Line of Custom and Imprintable Coloring Books 2Health News:Infection-Control Strategies at Leading Hospital Can be Adapted for Everyday Use 2Health News:Infection-Control Strategies at Leading Hospital Can be Adapted for Everyday Use 3Health News:Infection-Control Strategies at Leading Hospital Can be Adapted for Everyday Use 4Health News:Research sheds light on workings of anti-cancer drug 2Health News:Research sheds light on workings of anti-cancer drug 3
...d that DDT can cause developmental delays in infan... While DDT is currently banned in the United Sta... combat mosquitoes that spread malaria. Accordi... benefits of DDT use to reduce malaria must be con...
...tish tourists face several health risks are riskin... anti malaria pills before they go abroad//. T...ople have visited tropical countries on holiday ov...r cent of British tourists who have visited count...
...sters to approve a progress report on a national p...nancial// help of the federal government to cover ... in Fredericton was planned to be conducted withou...dication of help to pay for the initiative. Acc...
... and scientist are still doing exhaustive research...ope to millions of sick and disabled people that t...world's first clone of an adult mammal. From then ...bryonic stem cell branched out, or differentiated,...
...olved in tumor-suppression or cell-proliferation-s...of pancreatic islet cells, which again affected bl...sity of Pennsylvania School of Medicine reports. ...plications for diabetes treatment. MEN1 patien...
...ith psychological problems into adulthood. A new s...lity of life can be used to learn about the psycho...ntion and treatment. Oral clefting is one o...n experience challenging psychological adjustment ...
Other Medicine News:Health News:Developmental Delays in Infants Linked to DDT 2Health News:Tourists Face Health Risks by Missing Vaccinations 2Health News:Clement Urged to Plot a National Pharmaceutical Strategy 2Health News:Dolly Paves the Way for Exhaustive Stem Cell Research 2Health News:Menin Gene Mutation made Insulin Secreting Cells to Proliferate 2Health News:Learning the Value of Prevention and Treatment in Oral Clefting 2
(Date:11/29/2009)...swire/ -- Royal Philips Electronics ( PHG, AEX: PH...d by showing its portfolio of products designed to...meeting of the Radiological Society of North Ameri...are several advancements and upgrades focused on r...eamlining workflow to expand upon clinical capabil...
(Date:11/29/2009)...wire/ -- FUJIFILM Medical Systems USA, Inc., the w...M) with over 7,000 installations, is pleased to de...in the US. The Aspire HD combines the use of adva...eration detector technology and the smallest pixel...solution at a reduced dose for the patient. The f...
(Date:11/29/2009)...e/ -- Researchers using functional magnetic resona...found that men and women respond differently to po...presented today at the annual meeting of the Radio...n may direct more attention to sensory aspects of ...s of implications for required action, whereas wom...
Breaking Medicine Technology:Philips Responds to Industry Concerns With Focus on Radiation Dose Management Products Designed for Clinicians and Patients 2Philips Responds to Industry Concerns With Focus on Radiation Dose Management Products Designed for Clinicians and Patients 3Philips Responds to Industry Concerns With Focus on Radiation Dose Management Products Designed for Clinicians and Patients 4Philips Responds to Industry Concerns With Focus on Radiation Dose Management Products Designed for Clinicians and Patients 5FUJIFILM's DR-based FFDM System Makes US Debut at RSNA 2FUJIFILM's DR-based FFDM System Makes US Debut at RSNA 3FUJIFILM's DR-based FFDM System Makes US Debut at RSNA 4New Study Finds Men and Women May Respond Differently to Danger 2New Study Finds Men and Women May Respond Differently to Danger 3Catholics to Rally at USCCB Headquarters in Washington DC Re 3A Healthcare Our Bishops and Abortion 58079 1Catholics to Rally at USCCB Headquarters in Washington DC Re 3A Healthcare Our Bishops and Abortion 58079 2BioMarin Initiates Phase 2 Clinical Study of PEG PAL in PKU 5031 1BioMarin Initiates Phase 2 Clinical Study of PEG PAL in PKU 5031 2BioMarin Initiates Phase 2 Clinical Study of PEG PAL in PKU 5031 3Georgia State researcher to use 241 million grant to improve computer models for fighting wildfires 10045 1Georgia State researcher to use 241 million grant to improve computer models for fighting wildfires 10045 2
...nificant Anti-Tumor Effects of Targeted, Systemic,...n the Limits of,Safe Administrations in Rodent and...007 /PRNewswire/ -- Calando,Pharmaceuticals, a lea...ed subsidiary of Arrowhead Research Corporation,pr...esting in mice,using multiple, systemic dosing wit...
...lif.--(BUSINESS WIRE)--Apr 16, 2007 - Amgen,(Nasda...zed,double-blind, placebo-controlled Phase 3 stud... (darbepoetin alfa) for the,treatment of anemia in...erapy or radiotherapy ("the 103 study"). Aranesp i... patients. These,results were presented in an oral...
Other Medicine Technology:Calando Pharmaceuticals Announces Preclinical Efficacy and Safety,Data of Targeted, Systemic Delivery of siRNA at AACR Annual Meeting 2Calando Pharmaceuticals Announces Preclinical Efficacy and Safety,Data of Targeted, Systemic Delivery of siRNA at AACR Annual Meeting 3Calando Pharmaceuticals Announces Preclinical Efficacy and Safety,Data of Targeted, Systemic Delivery of siRNA at AACR Annual Meeting 4Aranesp Phase 3 Study in Patients with Active Cancer Not Receiving,Concurrent Chemotherapy or Radiotherapy Presented at AACR Annual,Meeting 2Aranesp Phase 3 Study in Patients with Active Cancer Not Receiving,Concurrent Chemotherapy or Radiotherapy Presented at AACR Annual,Meeting 3Aranesp Phase 3 Study in Patients with Active Cancer Not Receiving,Concurrent Chemotherapy or Radiotherapy Presented at AACR Annual,Meeting 4Aranesp Phase 3 Study in Patients with Active Cancer Not Receiving,Concurrent Chemotherapy or Radiotherapy Presented at AACR Annual,Meeting 5Aranesp Phase 3 Study in Patients with Active Cancer Not Receiving,Concurrent Chemotherapy or Radiotherapy Presented at AACR Annual,Meeting 6Aranesp Phase 3 Study in Patients with Active Cancer Not Receiving,Concurrent Chemotherapy or Radiotherapy Presented at AACR Annual,Meeting 7
Force EZ Electrosurgical Generator
Black Multi-Pinhole Occluder
49 Pinhole short handle
Frosted Long Handle Occluder
Medicine Products: